The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
vNN Web Server for ADMET Predictions
Open accessAbstract
In drug development, early assessments of pharmacokinetic and toxic properties are important stepping stones to avoid costly and unnecessary failures. Considerable progress has recently been made in the development of computer-based (in silico) models to estimate such properties. Nonetheless, such models can be further improved in terms of their ability to make predictions more rapidly, easily, and with greater reliability. To address this issue, we have used our vNN method to develop 15 absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction models. These models quickly assess some of the most important properties of potential drug candidates, including their cytotoxicity, mutagenicity, cardiotoxicity, drug-drug interactions, microsomal stability, and likelihood of causing drug-induced liver injury. Here we summarize the ability of each of these models to predict such properties and discuss their overall performance. Using a 10-fold cross-validation procedure, we show that each model has an accuracy of greater than 75%. All of these ADMET models are publically available on our website (https://vnnadmet.bhsai.org/), which also offers the capability of using the vNN method to customize and build new models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Daina, A., Michielin, O., & Zoete, V. (2017) · Scientific Reports · doi:10.1038/srep42717 · Cited by 18,367
Extended-Connectivity Fingerprints
Rogers, D., & Hahn, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100050t · Cited by 7,524
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Ames, B. N., Durston, W. E., Yamasaki, E., & Lee, F. D. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.8.2281 · Cited by 2,276
admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties
Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300367a · Cited by 2,222
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Mammalian ABC Transporters in Health and Disease
Borst, P., & Elferink, R. O. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102301.093055 · Cited by 1,571
The ChEMBL bioactivity database: an update
Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Krüger, F. A., Light, Y., Mak, L., McGlinchey, S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1031 · Cited by 1,492
PubChem: a public information system for analyzing bioactivities of small molecules
Wang, Y., Xiao, J., Suzek, T. O., Zhang, J., Wang, J., & Bryant, S. H. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp456 · Cited by 1,467
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4609 · Cited by 1,450
P-glycoprotein: from genomics to mechanism
Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E., & Gottesman, M. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206948 · Cited by 1,074
Adler, J., & Parmryd, I. (2010) · Cytometry Part A · doi:10.1002/cyto.a.20896 · Cited by 1,054
Sushko, I., Novotarskyi, S., Körner, R., Pandey, A. K., Rupp, M., Teetz, W., Brandmaier, S., Abdelaziz, A., Prokopenko, V. V., Tanchuk, V. Y., et al. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9440-2 · Cited by 686
Mitochondrial dysfunction and molecular pathways of disease
Pieczenik, S. R., & Neustadt, J. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.09.008 · Cited by 637
Mitochondria as a Target of Environmental Toxicants
Meyer, J. N., Leung, M. C. K., Rooney, J. P., Sendoel, A., Hengartner, M. O., Kisby, G. E., & Bess, A. S. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft102 · Cited by 562
Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury
Xu, J. J., Henstock, P. V., Dunn, M. C., Smith, A. R., Chabot, J. R., & de Graaf, D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn109 · Cited by 492
Zheng, W., & Tropsha, A. (2000) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci980033m · Cited by 450
Duan, J., Dixon, S. L., Lowrie, J. F., & Sherman, W. (2010) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2010.05.008 · Cited by 439
FDA-approved drug labeling for the study of drug-induced liver injury
Chen, M., Vijay, V., Shi, Q., Liu, Z., Fang, H., & Tong, W. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.05.007 · Cited by 406
Deep Learning for Drug-Induced Liver Injury
Xu, Y., Dai, Z., Chen, F., Gao, S., Pei, J., & Lai, L. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00238 · Cited by 382
Time-Split Cross-Validation as a Method for Estimating the Goodness of Prospective Prediction.
Sheridan, R. P. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400084k · Cited by 376
Benchmark Data Set for in Silico Prediction of Ames Mutagenicity
Hansen, K., Mika, S., Schroeter, T., Sutter, A., ter Laak, A., Steger-Hartmann, T., Heinrich, N., & Müller, K.-R. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900161g · Cited by 370
EXPLAINED VARIATION FOR LOGISTIC REGRESSION
Mittlböck, M., & SCHEMPER, M. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19961015)15:19<2121::aid-sim346>3.0.co;2-m · Cited by 335
Hert, J., Willett, P., Wilton, D. J., Acklin, P., Azzaoui, K., Jacoby, E., & Schuffenhauer, A. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b409865j · Cited by 260
Huang, R., Xia, M., Nguyen, D.-T., Zhao, T., Sakamuru, S., Zhao, J., Shahane, S. A., Rossoshek, A., & Simeonov, A. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00085 · Cited by 227
Chen, L., Li, Y., Zhao, Q., Peng, H., & Hou, T. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100465q · Cited by 183
Wang, S., Li, Y., Wang, J., Chen, L., Zhang, L., Yu, H., & Hou, T. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300023x · Cited by 180
A Novel Approach for Predicting P-Glycoprotein (ABCB1) Inhibition Using Molecular Interaction Fields
Broccatelli, F., Carosati, E., Neri, A., Frosini, M., Goracci, L., Oprea, T. I., & Cruciani, G. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101421d · Cited by 176
lazar: a modular predictive toxicology framework
Maunz, A., Gütlein, M., Rautenberg, M., Vorgrimmler, D., Gebele, D., & Helma, C. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00038 · Cited by 174
Attene-Ramos, M. S., Huang, R., Michael, S., Witt, K. L., Richard, A., Tice, R. R., Simeonov, A., Austin, C. P., & Xia, M. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1408642 · Cited by 172
De Ponti, F., Poluzzi, E., & Montanaro, N. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100290 · Cited by 171
Developing Structure−Activity Relationships for the Prediction of Hepatotoxicity
Greene, N., Fisk, L., Naven, R. T., Note, R. R., Patel, M. L., & Pelletier, D. J. (2010) · Chemical Research in Toxicology · doi:10.1021/tx1000865 · Cited by 171
Qualitative prediction of blood–brain barrier permeability on a large and refined dataset
Muehlbacher, M., Spitzer, G. M., Liedl, K. R., & Kornhuber, J. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9478-1 · Cited by 163
Li, D., Chen, L., Li, Y., Tian, S., Sun, H., & Hou, T. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400450m · Cited by 141
Di, L., Kerns, E. H., Hong, Y., et al. (2003) · SLAS DISCOVERY · doi:10.1177/1087057103255988 · Cited by 136
Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates
Brown, C. M., Reisfeld, B., & Mayeno, A. N. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530701836662 · Cited by 136
Murray, M. T. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.7.0001 · Cited by 124
Mixed learning algorithms and features ensemble in hepatotoxicity prediction
Liew, C. Y., Lim, Y. C., & Yap, C. W. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9468-3 · Cited by 113
Brown, C. M., Reisfeld, B., & Mayeno, A. N. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530802309742 · Cited by 111
Contrera, J. F., Matthews, E. J., Kruhlak, N. L., & Benz, R. D. (2004) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2004.08.004 · Cited by 90
Chembench: a cheminformatics workbench
Walker, T., Grulke, C., Pozefsky, D., & Tropsha, A. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq556 · Cited by 71
Naef, R. (2015) · Molecules · doi:10.3390/molecules201018279 · Cited by 60
Critically Assessing the Predictive Power of QSAR Models for Human Liver Microsomal Stability
Liu, R., Schyman, P., & Wallqvist, A. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00255 · Cited by 55
Self-citationCzodrowski, P. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400308z · Cited by 53
Human drug hepatotoxicity: a contemporary clinical perspective
Assis, D. N., & Navarro, V. J. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902927386 · Cited by 50
Liu, R., Tawa, G. J., & Wallqvist, A. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300279f · Cited by 48
Self-citationManganaro, A., Pizzo, F., Lombardo, A., Pogliaghi, A., & Benfenati, E. (2015) · Chemosphere · doi:10.1016/j.chemosphere.2015.10.054 · Cited by 40
Merging Applicability Domains for in Silico Assessment of Chemical Mutagenicity
Liu, R., & Wallqvist, A. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500016v · Cited by 34
Self-citationUsing the Variable-Nearest Neighbor Method To Identify P-Glycoprotein Substrates and Inhibitors
Schyman, P., Liu, R., & Wallqvist, A. (2016) · ACS Omega · doi:10.1021/acsomega.6b00247 · Cited by 19
Self-citation
Cited by
Xiong, G., Wu, Z., Yi, J., Fu, L., Yang, Z., Hsieh, C., Yin, M., Zeng, X., Wu, C., Lu, A., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab255 · Cited by 2,857
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“…are publicly available like ChEMBL, PubChem, and ZINC, we have access to millions of compounds annotating information like their structure, known targets and purchasability; MMP plus ML can predict bioactivity like oral exposure, intrinsic clearance, ADMET, and method of action [98, 104, 105].”
BackgroundDong, J., Wang, N.-N., Yao, Z.-J., Zhang, L., Cheng, Y., Ouyang, D., Lu, A.-P., & Cao, D.-S. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0283-x · Cited by 889
ADMET modeling approaches in drug discovery
Ferreira, L. L. G., & Andricopulo, A. D. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.015 · Cited by 825
Advancing drug discovery via artificial intelligence
Chan, H. C. S., Shan, H., Dahoun, T., Vogel, H., & Yuan, S. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.06.004 · Cited by 654
Metadata
- Authors
- Schyman, P., Liu, R., Desai, V., & Wallqvist, A.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-12-04
- Volume
- 8
- Pages
- 889-889
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2775175656
- Cited by
- 254
- References
- 51
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.